Safety, efficacy, and pharmacokinetics of bedaquiline in Japanese patients with pulmonary multidrug-resistant tuberculosis: An interim analysis of an open-label, phase 2 study
2019 ◽
Vol 57
(4)
◽
pp. 345-353
◽
2019 ◽
Vol 110
(6)
◽
pp. 665-674
◽
Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
2011 ◽
Vol 17
(21)
◽
pp. 6905-6913
◽
Keyword(s):
Phase 2
◽